The Globe and Mail17h
Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024
a next generation multi-specific CD3 Switch-DARPin with enhanced function to tackle the current limitations of T cell engagers in ovarian cancer Both posters will be made available on Molecular ...
Latest findings from the South Pole Telescope bolster standard cosmological model
Roughly 400,000 years after the Big Bang, the universe cooled just enough to allow photons to escape from the primordial ...
Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024
Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune ...
The New York Times17h
New York Times - Top Stories
Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...
National Geographic news11h
November 2024 Issue
In the medical field, being fast, efficient, and correct can be the difference between life and death. This game-changing tool is helping cancer researchers and doctors save lives.